Continuation Review Report
DHHS regulation 45CFR46.109(e) requires that the IRB review human subjects research at intervals appropriate to the degree of risk, but not less than once per year.
To ensure that all studies are reviewed and approved on an annual basis, the IRO will send you a reminder notice through interoffice mail several weeks before you CRR is due.
If you are doing a Clinical Research Division or Cancer Consortium study, the Protocol Office will email you all appropriate forms and current study documents, and submit your documents to the IRB.
|
Updated June 30, 2009
In July, the Continuation Review Report (CRR) was revised to reflect the updated policy changes on Unanticipated Problems Involving Risks to Subjects or Others (2.6), Reporting Obligations for Principal Investigators (1.11) and Noncompliance (1.9) and to incorporate users' feedback.
The IRO recently updated the first page of the CRR for administrative purposes only (e.g. added the FHCRC Registration Identification's expiration date). The latest version of the CRR is version 4.01, effective August 5, 2009. CRRs submitted on or after September 1, 2009 must use this version.
Please contact James Riddle, IRO Assistant Director at 667-6501 or Denelle Reilly, IRB Operations Manager at 667-6567 with any questions/concerns regarding these changes. |
Submission Instructions
- Submit original documents only (no copies required).
- All documents must be single-sided. Please do not use staples.
- It is recommended that a complete set of the documents submitted to the IRB is kept for your records.
Full Review
Please submit the following original document.
Submit the following documents, if applicable. Submit only the documents that the study is currently using or will use in the next approval period.
- Synopsis
- Protocol
- Consent Form(s)
- Flyers/Advertisements
- Approach Letters
- Questionnaires
- Investigator Brochure (include a summary of changes)
- Data Safety Monitoring Board (DSMB) and Multi-center reports
- PDMC/SRC Result Letter(s)
- Summary of the current approval period's Modifications
- Approved Modifications Forms from the current approval period
- Other study documents
- Current Protocol Modification Form
- Prisoner Certification Checklist for Investigator
- Statistical Center Supplement
- Coordinating Center Operationis Supplement
- International Research Performance Site Assessment Supplement
- Repository, Registry or Databank Supplement Form
- UW Confidentiality Agreement Form or Seattle Children's Oath of Confidentiality Form
- HIPAA Form
- Funding Source Supplement [download Word doc] and one copy of the Funding Source Document and face page (if a new funding source is being added to the IR File)
Miminal Risk
Please submit the following original documents.
- CRR Form
- Expedited Review Checklist for Minimal Risk Activities [download Word doc]
- Protocol
- Consent (the most current approved consent form used by research participants)
Submit the following documents, if applicable. Submit only the documents that the study is currently using or will use in the next approval period.
- Synopsis
- Flyers/Advertisements
- Approach Letters
- Questionnaires
- Investigator Brochure (include a summary of changes)
- Data Safety Monitoring Board (DSMB) and Multi-center reports
- PDMC/SRC Result Letter(s)
- Summary of the current approval period's Modifications
- Approved Modifications Forms from the current approval period
- Other study documents
- Current Protocol Modification Form
- Prisoner Certification Checklist for Investigator
- Statistical Center Supplement
- Coordinating Center Operationis Supplement
- International Research Performance Site Assessment Supplement
- Repository, Registry or Databank Supplement Form
- UW Confidentiality Agreement Form or Seattle Children's Oath of Confidentiality Form
- HIPAA Form
- Funding Source Supplement [download Word doc] and one copy of the Funding Source Document and face page (if a new funding source is being added to the IR File)
Cooperative or IRB Authorization Agreement Review
Submit one copy of:
- Page 1 of the CRR [download word]
- Approved (signed, with current dates of approval) copies of the cooperative institution's continuation review document(s)
- Protocol or Activity Plan (only if modified)
- Consent Form(s) (only if modified)
Exempt Review
Original documents only.
Other Considerations
If you have questions regarding the Cancer Consortium IRB and/or the submission process, please go to www.cancerconsortium.org.
If you are reporting a "Closure", a CRR that includes a final summary is required. If the study was never activated (i.e., no subjects entered), you may indicate this on page 1 of the CRR.
If any documents, such as consent forms use acronyms, please be sure to spell each acronym completely when first using them. For example, Institutional Review Board (IRB).
Once the application receives final approval, the IRO will forward one copy of the approved documents to the Contact Person.